R
Replimune Group, Inc. (REPL)
7.22
0.00 (0.00%)

7.22
0.00 (0.00%)
| Состав | |
|---|---|
| 2.18% | % акций у инсайдеров |
| 97.23% | % акций у институциональных инвесторов |
| 99.40% | % свободных акций у институциональных инвесторов |
| 220 | Количество институциональных инвесторов |
| Держатель | Акции | Дата отчёта | % от объёма | Стоимость |
|---|---|---|---|---|
| Baker Bros. Advisors, LP | 11.05M | 2025-12-31 | 13.38% | $79.75M |
| Price (T.Rowe) Associates Inc | 8.26M | 2025-12-31 | 10.01% | $59.65M |
| RTW Investments LP | 7.14M | 2025-12-31 | 8.65% | $51.55M |
| Blackrock Inc. | 6.07M | 2025-12-31 | 7.35% | $43.82M |
| Vanguard Group Inc | 3.78M | 2025-12-31 | 4.57% | $27.26M |
| State Street Corporation | 3.69M | 2025-12-31 | 4.47% | $26.66M |
| FMR, LLC | 2.98M | 2025-12-31 | 3.61% | $21.53M |
| FCPM III Services B.V. | 2.81M | 2025-12-31 | 3.40% | $20.28M |
| Shaw D.E. & Co., Inc. | 2.58M | 2025-12-31 | 3.12% | $18.59M |
| Toronto Dominion Bank | 2.23M | 2025-12-31 | 2.70% | $16.10M |
| Держатель | Акции | Дата отчёта | % от объёма | Стоимость |
|---|---|---|---|---|
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 2.47M | 2026-01-31 | 2.99% | $17.85M |
| T. Rowe Price New Horizons Fund, Inc. | 2.44M | 2025-12-31 | 2.95% | $17.59M |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.44M | 2026-01-31 | 2.95% | $17.58M |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.85M | 2025-12-31 | 2.24% | $13.34M |
| iShares Trust-iShares Russell 2000 ETF | 1.67M | 2026-01-31 | 2.03% | $12.09M |
| T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U. | 1.60M | 2025-12-31 | 1.94% | $11.55M |
| T. Rowe Price Health Sciences Fund, Inc. | 1.47M | 2025-12-31 | 1.78% | $10.62M |
| -Price (T.Rowe) New Horizons Trust | 927,126 | 2025-09-30 | 1.12% | $6.69M |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 771,065 | 2025-12-31 | 0.93% | $5.57M |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 678,844 | 2025-12-31 | 0.82% | $4.90M |